Fund Overview
The State Street Health Care Select Sector SPDR ETF, identified by the ticker XLV, is a financial instrument categorized within the Health sector and is managed by the State Street Investment Management fund family. This exchange-traded fund maintains total assets under management of $43.12 billion, a figure that signifies substantial scale and indicates strong popularity among institutional and retail participants seeking exposure to the healthcare industry. While the specific number of individual holdings is not publicly disclosed in the provided data, the asset class nature of the fund implies a structure designed to capture a broad segment of the health care sector. The fund charges an expense ratio of 0.1%, which is a low-cost metric relative to many actively managed funds and many passive sector competitors, suggesting that the fund is structured to minimize fees that would otherwise erode investor returns over time.
Performance Analysis
The XLV ETF currently offers a yield of 1.6%, a metric that provides a baseline for income-seeking investors who are looking for passive income generation alongside capital appreciation potential. Year-to-date, the fund has recorded a return of 3.5%, providing a snapshot of its recent performance trajectory relative to the start of the calendar year. Over a longer horizon, the fund has demonstrated consistent compounding with a 3-year average return of 5.6% and a 5-year average return of 5.8%, indicating that the underlying assets have delivered steady growth over multiple economic cycles. The comparison between the short-term YTD return of 3.5% and the long-term averages reveals that recent performance is slightly below the 5-year average of 5.8% but closely tracks the 3-year average of 5.6%, suggesting that recent market fluctuations have not drastically altered the fund's historical trend. The low expense ratio of 0.1% plays a critical role in preserving net returns over time, ensuring that the gross returns generated by the portfolio are not significantly diminished by management fees compared to higher-cost alternatives.
Price & Risk Profile
The price action for XLV has fluctuated within a defined band, with a 52-week high of $160.59 and a 52-week low of $127.35, illustrating the range over which the share price has traded during the last year. The existence of this price range indicates that the fund experiences volatility typical of sector-specific investments, reacting to changes in the broader healthcare industry and general market conditions. Without the current share price explicitly listed in the available facts, the precise location within the 52-week range cannot be calculated; however, the spread between the high and low of approximately $33.24 suggests a notable degree of price movement that investors must account for. The beta value is not available in the provided data, so a direct comparison of volatility relative to the broader market index cannot be quantified based on the available metrics. Consequently, the overall risk profile is best summarized by the asset class concentration in health care and the observed price volatility, meaning that the fund's value will move in tandem with the specific health care sector rather than providing a perfectly hedged position against broader market downturns.